HH Sheikh Mohammed bin Rashid Al Maktoum Inaugurates 200MW Second Phase of the Mohammed bin Rashid Al Maktoum Solar Park
HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of UAE and Ruler of Dubai, has inaugurated the 200 megawatt (MW) second phase of the Mohammed bin Rashid Al Maktoum Solar Park. The project reflects a new era in the excellence and leadership of the UAE, as it increases the share of clean and renewable energy. The inauguration coincided with the International Day of Happiness.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170320005935/en/
HE Saeed Mohammed Al Tayer speaking at the inauguration of the second phase of the Mohammed bin Rashid Al Maktoum Solar Park (Photo: ME NewsWire)
This phase of the solar park is the first and largest solar-energy project in the region, based on the Independent Power Producer (IPP) model. It was accomplished through a partnership between DEWA and the consortium led by ACWA Power from Saudi Arabia, the main developer of the project, and TSK from Spain, the main contractor, with an investment of AED 1.2 billion. This phase can generate clean energy for 50,000 residences in Dubai, and will reduce 214,000 tonnes of carbon emissions annually. This phase installed 2.3 million photovoltaic solar panels over 4.5 square kilometres with 1.5 million Safe Man Hours without Lost Time Injury during project execution. The efforts of Shuaa Energy 1, which was established by DEWA and the consortium led by ACWA Power and TSK, have been vital in completing the work efficiently and professionally.
“The UAE’s strategies and investments are clear evidences that it is today leading international efforts in clean and renewable energy. The second phase of the Mohammed bin Rashid Al Maktoum Solar Park, which is a national landmark that will contribute to the happiness of society and generations to come, adds to the blessed progress of the UAE under the leadership of His Highness Sheikh Khalifa bin Zayed Al Nahyan, President of the UAE, and the directives of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai. The UAE puts sustainability and diversification of energy sources at the forefront of its priorities, based on a forward-looking vision that shapes the future, focuses on the happiness of people, and balances the need for development with the preservation of our environment. The Mohammed bin Rashid Al Maktoum Solar Park reflects our commitment to build a better, brighter, and more sustainable future for generations to come. The significance of the solar park is not only in combining the efforts of the public and private sectors in solar energy, but also in hosting a Research & Development centre that will include a photovoltaic solar testing facility, which is set to become one of the largest in the region,” said HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA).
“Our success in completing this phase of the Mohammed bin Rashid Al Maktoum Solar Park, which will generate 200 megawatts of clean energy ahead of schedule, is a direct result of the unlimited support of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai. The insightful vision of His Highness is both an inspiration and a guiding beacon in our drive towards excellence and the unprecedented overall progress that we have made to achieve the Dubai Clean Energy Strategy 2050 to generate 7% of Dubai’s total power output from clean energy by 2020, 25% by 2030, and 75% by 2050. The Mohammed bin Rashid Al Maktoum Solar Park is one of the major projects that DEWA implements to achieve this promising strategy. It is the largest single-site solar park in the world, based on the IPP model, with a planned capacity of 1,000 megawatts by 2020 and 5,000 megawatts by 2030, with a total investment of AED50 billion. It will eventually save over 6.5 million tonnes of carbon emissions every year, supporting Dubai’s objectives to promote sustainable development and a green economy,” added Al Tayer.
“The UAE’s interest in producing renewable energy has contributed to the decline of its global cost to competitive levels. This was clearly shown by DEWA setting a world record, obtaining the lowest price globally for the second phase of the solar park, at USD 5.6 cents per kilowatt hour. DEWA set another world record with the lowest recorded bid being USD 2.99 cents per kW/h for the 800 megawatt third phase of the solar park. This demonstrates the promising future of clean energy,’ said Al Tayer.
To view a video on Mohammed bin Rashid Al Maktoum Solar Park, Please click here .
*Source: ME NewsWire
Dubai Electricity and Water Authority
Ribal Dayekh / Iman Saeed, +971-4-515-1784
email@example.com / firstname.lastname@example.org
Orient Planet PR
Jessy Chami / Rawad Khattar
email@example.com / firstname.lastname@example.org
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28 | Pressemelding
Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (http://www.elektroniknet.de), a leading German electronics publication. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005646/en/ Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05 | Pressemelding
Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52 | Pressemelding
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50 | Pressemelding
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00 | Pressemelding
Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at www.aitheon.com/news) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180323005269/en/ Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on